Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Digital Health

And More Things Overheard at Wharton's 2020 Health Care Business Conference

Highlights included Humana's SDOH announcement, an emphasis on erasing patient stigma, and putting people before tech.

The healthcare industry is finally coming to terms with the fact that disruption is here.

Partner, Health & Life Sciences, Oliver Wyman

Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.

Partner, Health & Life Sciences, Oliver Wyman
Executive Chairman, President and CEO, Click Therapeutics
Former CEO, SyncThink
CEO, AbleTo

Healthcare leaders will convene in California to discuss healthcare reform, price transparency, moonshots, and more. Follow along with us live online.

Editor, Health & Life Sciences, Oliver Wyman

Here's how we did on last year's predictions and what emerging trends to expect next.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

And Other Key Takeaways from #OWHIC, Asia Edition

Asia has been quick to experiment in innovative customer journeys. But, patients are impatient.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Changes are already here, they're real, and we believe they'll scale quickly.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Senior Consultant, Oliver Wyman

What the future may hold for four big company names looking to become big names in healthcare.

Partner, Health & Life Sciences, Oliver Wyman

Companies able to anticipate changes in the customer’s lifestyle and mindset are best positioned to benefit from the $100 trillion digital dividend. But there are risks.

Managing Director of Digital, Technology and Innovation, Marsh & McLennan Solutions

Insights in your inbox

Subscribe